11 Sep 2024 | 03:00 PM GMT
Past Meeting

Masterclass: Partnerships in AI Drug Discovery

Participants:

Dr Martin Gershon Managing Partner & CIOEndeavor Life Science Venture Funds
Dr Martin Gershon
Managing Partner & CIOEndeavor Life Science Venture Funds
Julie Carty Head of Strategy & GrowthHLTH Community
Julie Carty
Head of Strategy & GrowthHLTH Community
Andrii Savytskyi Head of BD DeHealthStartup
Startup
Andrii Savytskyi
Head of BD DeHealth
ARTURO LOAIZA-BONILLA Co-Founder and Chief Medical AI OfficerMassive BioHealth Tech & Solutions
Health Tech & Solutions
ARTURO LOAIZA-BONILLA
Co-Founder and Chief Medical AI OfficerMassive Bio
Chris Cera CEOArcweb TechnologiesHealth Tech & Solutions
Health Tech & Solutions
Chris Cera
CEOArcweb Technologies
Christian Hein Executive AdvisorIndependentProfessional Services
Professional Services
Christian Hein
Executive AdvisorIndependent
Ciara Clancy Chief Executive OfficerBeats Medical LtdHealth Tech & Solutions
Health Tech & Solutions
Ciara Clancy
Chief Executive OfficerBeats Medical Ltd
Danny Bosch Associate Director BD and CommercialImperial College Health PartnersLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Danny Bosch
Associate Director BD and CommercialImperial College Health Partners
PD
Petar Dimov CTOSUSEHealth Tech & Solutions
PD
Health Tech & Solutions
Petar Dimov
CTOSUSE
Ruth Gross VP Business DevelopmentEvogeneLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Ruth Gross
VP Business DevelopmentEvogene
Yury Rozenman SVP Business Development Life SciencesAda HealthHealth Tech & Solutions
Health Tech & Solutions
Yury Rozenman
SVP Business Development Life SciencesAda Health

About this Meeting

This masterclass is designed to explore partnerships relating to AI in drug discovery, including the importance of innovation, strategy, and steps to commercialization.

Join this meeting to discuss numerous topics on navigating this market, including:

Accelerated Lead Identification: can AI drastically reduce the time required for lead identification in drug discovery, which is crucial for rare diseases?

Optimized Drug Design: can AI enhance drug design by intelligently tweaking molecular structures, reducing side effects, and improving efficacy?

Predictive Analysis in Clinical Trials: can AI streamline clinical trials concerning patient responses, making trials more efficient and reducing the overall time and cost to bring new drugs to market?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 - 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: June 21 - 24 | Amsterdam
2028 | HLTH Europe: June 19 - 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.